India, April 4 -- Following the inspection by the United States Food and Drug Administration (USFDA) at the Goa manufacturing facility from 21st - 28th January, 2019, Cipla Ltd has received the Establishment Inspection Report (EIR), indicating closure of the inspection.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....